How AI is helping to improve Parkinson’s treatment, reduce symptoms for patients
A new adaptive deep brain stimulation system using artificial intelligence has been approved by the FDA to treat Parkinson's disease, personalizing treatment based on a patient's brain activity. The system, approved in February 2025, adjusts treatment in real time to help reduce symptoms for patients like Rick Schena.
More than 1.1 million Americans live with Parkinson's disease, a neurodegenerative disorder causing stiff limbs, slow movement, and tremors. A new adaptive deep brain stimulation system using artificial intelligence has been approved by the FDA to treat the condition. The system personalizes treatment based on a patient's brain activity and adjusts in real time. Rick Schena, a patient diagnosed with Parkinson's nearly two decades ago, underwent deep brain stimulation surgery in fall 2024. The new adaptive system, approved in February 2025, aims to address limitations of traditional deep brain stimulation, such as reduced effectiveness during exercise or stress. Early studies showed promising results for the new technology.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.